Research, News & Discoveries

The Vanderbilt Institute of Chemical Biology (VICB) will hold a Founders’ Celebration mini-symposium on March 28 to acknowledge the contributions of its founders, Lawrence Marnett, PhD, and Ned Porter, PhD, and to celebrate 15-plus years of success as a trans-institutional scientific incubator. The event, which is co-sponsored by the Department… Read More

Reporting last month in the journal Stem Cell Reports, Vanderbilt researchers found that a form of MCL-1 maintains stem cell pluripotency through its role in the inner matrix of mitochondria, the cell’s energy producing “power plants.” When this MCL-1 is depleted by an inhibitor, stem cells differentiate. MCL-1 depletion also changes the shape of mitochondria,… Read More

Eric Skaar, PhD, MPH, marvels at the images on his computer screen — 3-D molecular-level views of infection in a mouse. “I’m pretty convinced that these are the most advanced images in infection biology,” said Skaar, Ernest W. Goodpasture Professor of Pathology. Skaar and colleagues at Vanderbilt including James Cassat, MD,… Read More

Vanderbilt investigators and colleagues around the country have made a major discovery that could lead to better ways to treat type 1 diabetes (T1D). The discovery concerns glucagon, a hormone that opposes the actions of insulin in regulating glucose levels in the bloodstream. These two hormones are secreted by different… Read More

Long QT syndrome is a rare disorder that can lead to dangerous heart rhythms, fainting and sudden cardiac arrest. Inherited and potentially lethal forms of the disorder affect the structure and function of the KCNQ1 potassium channel, which transmits electrical signals crucial for maintaining regular heart rhythm. Now Charles Sanders, PhD, and… Read More

Boehringer Ingelheim and Vanderbilt University today announced the expansion of their successful existing collaboration to develop novel anti-cancer compounds. The expanded research partnership will focus on the discovery and development of new chemical therapeutics targeting the pro-survival protein MCL1 as a potential therapy against MCL1-dependent cancers. This is the third… Read More

Leading neuroscientist Lisa Monteggia has been named the Barlow Family Director of the Vanderbilt Brain Institute, Provost and Vice Chancellor for Academic Affairs Susan R. Wenteannounced today. Monteggia also will be a tenured member of the Vanderbilt faculty, pending approval by the Vanderbilt University Board of Trust. She will join the… Read More

Explaining Cardiac Arrhythmia The KCNQ1 potassium channel, in complex with the KCNE1 regulatory protein, is responsible for a delayed outward flow of potassium ions during the repolarization phase of the cardiac myocyte action potential. Mutations that result in loss of function (LOF) of KCNQ1 are associated with type 1… Read More

Christine Lovly, MD, PhD, assistant professor of Medicine, has received a $200,000 grant to support promising new research on lung cancer. The Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung Cancer (IASLC)have partnered to fund the Lori Monroe Scholarship for Lung Cancer Research. “I am honored to… Read More

Investigators at Vanderbilt-Ingram Cancer Center (VICC) and the Virginia Tech Carilion Research Institute (VTCRI) have revealed a gene mutation’s role in Von Hippel-Lindau syndrome, a genetically inherited disease which causes tumor growth in several organs. The study led by corresponding authors W. Kimryn Rathmell, MD, PhD, director of the Division of… Read More